All News

The landmark pharmaceutical reforms will not be adopted in this mandate, and the opposing views of the two rapporteurs mean the final text may not be ready to hand over to the next parliament, the Science|Business Health innovation conference hears

Over 40 years, the EU’s flagship research programmes have drifted from their early focus on collaborative, pre-competitive R&D benefiting industry and society. A Swedish expert on the programme calls for a rethink

The nuclear fusion project at ITER will be cut by €120M, while basic science and health and climate R&D get a bigger than expected top up in 2024

A surprise reshuffle heralds even more upheaval in UK science and technology policy. Meanwhile, the return of former prime minister David Cameron could see an easing of tensions with China, including in research

Scales to assess the likelihood of a new technology being accepted by consumers are helping to make sure innovators think about how their inventions will be received

Following Moscow’s invasion of Ukraine a fear of working with the West, sanctions, visa restrictions, travel issues and an exodus of academics have forced Russia to retreat from the global scientific conversation

With Europe’s launchers in crisis, a ‘paradigm shift’ in its relationship with industry will see the agency copy NASA in adopting a new procurement model in which it no longer owns and operates its own space vehicles

Voluntary initiatives have failed to ensure mutual recognition of qualifications across the EU. MEPs should be given greater authority to set quality standards and promote seamless mobility of students, says Sabine Verheyen MEP, chair of the education committee

Five years on from the launch of Plan S, global pressure for equitable, open and transparent scientific publishing is gathering a fresh head of steam

The nuclear industry has welcomed European Commission plans for a concerted effort on small modular reactors. A new international consortium plans to demonstrate the technology in Belgium

There is growing pressure on EU policymakers to play a role in promoting the development of psychedelics as medicines. The pharmaceutical regulations reform is an opportunity to incentivise research say MEPs

Two wars hung over this year’s get-together of scientists and politicians in Berlin. But there was still plenty of excitement, and trepidation, about new breakthroughs in AI, solar energy, and transatlantic science

The EDCTP partnership that sponsors clinical trials in Africa is a flagship of the EU’s health research effort. But as it reaches its 20 anniversary the pending pharmaceutical legislation and budget worries dog its future, warns Maria da Graça Carvalho MEP

Research commissioned by lobby group EFPIA shows Germany, Belgium and France will be among those hit hardest if the Commission’s proposals go ahead. In total, R&D would be cut by €2B per annum